首页> 美国卫生研究院文献>PLoS Clinical Trials >Gemini Surfactants Based on Bis-Imidazolium Alkoxy Derivatives as Effective Agents for Delivery of Nucleic Acids: A Structural and Spectroscopic Study
【2h】

Gemini Surfactants Based on Bis-Imidazolium Alkoxy Derivatives as Effective Agents for Delivery of Nucleic Acids: A Structural and Spectroscopic Study

机译:基于双咪唑烷氧基衍生物作为递送核酸的有效试剂的双子表面活性剂:结构和光谱研究

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The success rate of gene therapy depends on the efficient transfection of genetic material into cells. The golden mean between harmlessness and high effectiveness can be provided by synthetic lipid-like molecules that are similar to the components of biological membranes. Cationic gemini surfactants are one such moiety and because of their favourable physicochemical properties (double positive electric charge, reduced toxicity, low values of critical micelle concentration), they show great potential as delivery system components for genetic material in gene therapy. The aim of this study was to investigate the process of the complexation of cationic gemini surfactants with nucleic acids: double-stranded DNA of different sizes (21 bp, ~185 bp, ~20 kbp) and siRNA (21 bp). The tested series of dicationic surfactants consists of bis-imidazolium quaternary salts with varying lengths of hydrophobic side chains (m = 5, 6, 7, 8, 9, 11, 12, 14, 16). On the basis of the data obtained by circular dichroism spectroscopy and electrophoresis, we concluded that the studied gemini surfactants with long side chains effectively bind nucleic acids at low concentrations, which leads to the formation of stable lipoplexes. Images obtained by atomic force microscopy also confirmed the formation of vesicular structures, i.e., complexes between DNA and surfactants. The cytotoxicity of selected surfactants was also tested on HeLa cells. The surfactant toxicity significantly depends on surfactant geometry (the length of hydrophobic chain).
机译:基因治疗的成功率取决于遗传物质向细胞的有效转染。无害与高效之间的黄金中点可以通过类似于生物膜成分的合成类脂质分子来提供。阳离子双子表面活性剂就是这样一种成分,由于它们具有良好的理化特性(双正电荷,降低的毒性,临界胶束浓度的值低),它们在基因治疗中作为遗传物质的传递系统组分显示出巨大的潜力。这项研究的目的是研究阳离子双子表面活性剂与核酸的复合过程:不同大小(21 bp,〜185 bp,〜20 kbp)和siRNA(21 bp)的双链DNA。经过测试的系列表面活性剂由双咪唑季盐组成,这些盐具有不同长度的疏水性侧链(m = 5、6、7、8、9、11、12、14、16)。根据通过圆二色光谱和电泳获得的数据,我们得出结论,所研究的具有长侧链的双子表面活性剂可有效地结合低浓度的核酸,从而形成稳定的脂质复合物。通过原子力显微镜获得的图像也证实了囊泡结构的形成,即DNA和表面活性剂之间的复合物。还对HeLa细胞测试了所选表面活性剂的细胞毒性。表面活性剂的毒性很大程度上取决于表面活性剂的几何形状(疏水链的长度)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号